This study uses the type of breast cancer you are diagnosed with to determine what treatment you are given. You must be diagnosed with stage 2 or stage 3 breast cancer. This study requires regular MRI's.
Contact phoneCarolyn Krahulik | 517.364.2811
Principal investigatorDr. Brittani Thomas, DO